Követés
P. Kocsis
P. Kocsis
Gedeon Richter ltd
E-mail megerősítve itt: richter.hu
Cím
Hivatkozott rá
Hivatkozott rá
Év
Tumor volume estimation and quasi-continuous administration for most effective bevacizumab therapy
J Sápi, L Kovács, DA Drexler, P Kocsis, D Gajári, Z Sápi
PloS one 10 (11), e0142190, 2015
1312015
Tolperisone-type drugs inhibit spinal reflexes via blockade of voltage-gated sodium and calcium channels
P Kocsis, S Farkas, L Fodor, N Bielik, M Thán, S Kolok, A Gere, M Csejtei, ...
Journal of Pharmacology and Experimental Therapeutics 315 (3), 1237-1246, 2005
1082005
Blockers of voltage-gated sodium channels for the treatment of central nervous system diseases
I Tarnawa, H Bolcskei, P Kocsis
Recent Patents on CNS Drug Discovery (Discontinued) 2 (1), 57-78, 2007
972007
Simple pharmacological test battery to assess efficacy and side effect profile of centrally acting muscle relaxant drugs
S Farkas, P Berzsenyi, E Kárpáti, P Kocsis, I Tarnawa
Journal of Pharmacological and Toxicological methods 52 (2), 264-273, 2005
582005
Estradiol and isotype-selective estrogen receptor agonists modulate the mesocortical dopaminergic system in gonadectomized female rats
M Sárvári, L Deli, P Kocsis, L Márk, G Maász, E Hrabovszky, I Kalló, ...
Brain research 1583, 1-11, 2014
452014
NR2B containing NMDA receptor dependent windup of single spinal neurons
G Kovács, P Kocsis, I Tarnawa, C Horváth, Z Szombathelyi, S Farkas
Neuropharmacology 46 (1), 23-30, 2004
392004
Central sensitization-related changes of effective and functional connectivity in the rat inflammatory trigeminal pain model
T Spisák, Z Pozsgay, C Aranyi, S Dávid, P Kocsis, G Nyitrai, D Gajári, ...
Neuroscience 344, 133-147, 2017
302017
Comparative characterisation of the centrally acting muscle relaxant RGH-5002 and tolperisone and of lidocaine based on their effects on rat spinal cord in vitro.
S Farkas, P Kocsis, N Bielik
Neurobiology (Budapest, Hungary) 5 (1), 57-58, 1997
281997
Vascular action as the primary mechanism of cognitive effects of cholinergic, CNS-acting drugs, a rat phMRI BOLD study
P Kocsis, I Gyertyán, J Éles, J Laszy, N Hegedüs, D Gajári, L Deli, ...
Journal of Cerebral Blood Flow & Metabolism 34 (6), 995-1000, 2014
202014
Ghrelin modulates the fMRI BOLD response of homeostatic and hedonic brain centers regulating energy balance in the rat
M Sarvari, P Kocsis, L Deli, D Gajari, S David, Z Pozsgay, N Hegedűs, ...
PLoS One 9 (5), e97651, 2014
172014
Effect of tolperisone on the resting brain and on evoked responses, an phMRI BOLD study
P Kocsis, D Gajári, L Deli, KZ Gőcze, Z Pozsgay, K Tihanyi
Brain Research Bulletin 99, 34-40, 2013
162013
Mydeton: a centrally acting muscle relaxant drug from Gedeon Richter LTD
P Kocsis, I Tarnawa, G Kovács, Z Szombathelyi, S Farkas
Acta Pharmaceutica Hungarica 72 (1), 49-61, 2002
162002
Voltage-gated sodium channel blockers, 2001-2006: An overview
H Bölcskei, I Tarnawa, P Kocsis
Medicinal Chemistry Research 17, 356-368, 2008
152008
Concerted action of antiepileptic and antidepressant agents to depress spinal neurotransmission: Possible use in the therapy of spasticity and chronic pain
M Thán, P Kocsis, K Tihanyi, L Fodor, B Farkas, G Kovács, Á Kis-Varga, ...
Neurochemistry international 50 (4), 642-652, 2007
152007
Scopolamine provocation-based pharmacological MRI model for testing procognitive agents
N Hegedűs, J Laszy, I Gyertyán, P Kocsis, D Gajári, S Dávid, L Deli, ...
Journal of Psychopharmacology 29 (4), 447-455, 2015
122015
Recent advancements in anti-migraine drug research: focus on attempts to decrease neuronal hyperexcitability
H Bolcskei, B Farkas, P Kocsis, I Tarnawa
Recent Patents on CNS Drug Discovery (Discontinued) 4 (1), 14-36, 2009
112009
Participation of AMPA-and NMDA-type excitatory amino acid receptors in the spinal reflex transmission, in rat
P Kocsis, I Tarnawa, Z Szombathelyi, S Farkas
Brain research bulletin 60 (1-2), 81-91, 2003
102003
Effect of glutamate receptor antagonists on excitatory postsynaptic potentials in striatum
I Világi, P Kocsis, I Tarnawa, I Banczerowski-Pelyhe
Brain research bulletin 46 (6), 483-486, 1998
81998
Analysis of the mechanism of action, relationship between pharmacodynamics and pharmacokinetics of silperisone, a new centrally acting muscle relaxant
S Farkas, P Kocsis, N Bielik, L Gémesi, G Trafikânt
19th European Winter conference on Brain Research 98, 1999
71999
NR2B receptors are involved in the mediation of spinal segmental reflex potentials but not in the cumulative motoneuronal depolarization in vitro
P Kocsis, G Kovács, S Farkas, C Horváth, Z Szombathelyi, I Tarnawa
Brain research bulletin 64 (2), 133-138, 2004
42004
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20